Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

FibroGen, Inc (FGEN) had Stock-Based Compensation of $25.21M for the most recently reported fiscal quarter, ending 2024-12-31.

Quarterly Annual

Figures for fiscal quarter ending 2024-12-31

Income Statement Financials
Revenue	$-123.25M
Net Income	$17.98M
Cost of Goods Sold	$-20.66M
Gross Profit	$-102.59M
Operating Expenses	$-31.60M
Operating Income	$-91.66M
Non-Operating Income/Expense	$6.73M
Pre-Tax Income	$-84.92M
Normalized Pre-Tax Income	$-84.92M
Income after Taxes	$-84.87M
Income from Continuous Operations	$-87.54M
Consolidated Net Income/Loss	$17.98M
Normalized Income after Taxes	$-84.87M
EBIT	$-91.66M
EBITDA	$-91.30M
Weighted-Average Shares Outstanding (Basic)	100.04M
Weighted-Average Shares Outstanding (Diluted)	100.04M
Earnings per Share (EPS) (Basic)	$0.18
Earnings per Share (EPS) (Diluted)	$0.18
Balance Sheet Financials
Current Assets	$196.51M
Property, Plant, and Equipment	--
Long-Term Assets	$18.02M
Total Assets	$214.53M
Current Liabilities	$133.31M
Long-Term Debt	$73.09M
Long-Term Liabilities	$286.33M
Total Liabilities	$419.64M
Common Equity	$-205.12M
Tangible Shareholders Equity	$-205.12M
Shareholders Equity	$-205.12M
Common Shares Outstanding	100.92M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-138.00M
Cash Flow from Investing Activities	$125.99M
Cash Flow from Financial Activities	$-0.26M
Beginning Cash	$113.69M
End Cash	$102.18M
Increase/Decrease in Cash	$-11.51M
Stock-Based Compensation	$25.21M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.47
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-0.55
Debt to Equity Ratio	-0.36
Gross Margin	83.23%
Operating Margin	74.36%
EBIT Margin	74.36%
EBITDA Margin	--
Pre-Tax Profit Margin	68.90%
Profit Margin	-14.59%
Free Cash Flow	$-137.22M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	-0.57
Inventory Turnover	-6.55
Receiveable Turnover	-256.25
Days Sales in Receivables	-0.35
Return on Equity	42.68%
Return on Tangible Equity	42.68%
Return on Assets	-40.80%
Return on Investments	66.30%
Book Value Per Share	$-2.03
Free Cash Flow per Share	$-1.37
Operating Cash Flow per Share	$-1.38

Data from Zacks Investment Research, Inc.